<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2008</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2055391</full_dataset_link><location>Belgium</location><study_start_month>4</study_start_month><keyword>Colorectal Tumors</keyword><keyword>Colorectal Carcinoma</keyword><keyword>Zalutumumab</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer</name><description>The purpose of this trial is to determine the safety and efficacy of Zalutumumab alone or in combination with Irinotecan for the treatment of patients with Colorectal Cancer</description><dates><creation>2008-04-15</creation></dates><accession>2055391</accession><cross_references><ClinicalTrials___gov>NCT00677924</ClinicalTrials___gov></cross_references></HashMap>